YOU can advance research towards ReNU treatment options!

📌 Before enrolling in research, from ANY country, Create a Clinical Research ID (CRID)! This is crucial to using the research data collected across platforms and research programs. Once you create a CRID, share it with each clinical research study that you enroll in.

Example for CRID registration: Disease Name: ReNU Syndrome | Gene: RNU4-2 | Variant: n.64_65insT (or your variant)

If there was a treatment for your family member with ReNU syndrome, what would you want it to address? Your voice and perspective matters! This poll helps guide us towards identifying clinical endpoints for future potential treatments for ReNU.

Research Opportunities for Families

Citizen Health

Investigation of Newly Discovered Etiologies of Exceptional Disorders

Enroll - email zafiirah.baurhoo@mssm.edu

n-Lorem Foundation

Northwell Health logo with colorful triangles above the company name.

Clinical Health Survey

Enroll - email NGHI@northwell.edu

Rare-X Registry

Enrollment - Closed

Simons Searchlight

Infographic explaining a photo-based AI research study for rare disease diagnosis, featuring two smartphone screens displaying a child's facial photo and case results, with text on methods, study details, and contact information.

GestaltMatcher

Enroll - email annaarlt@uni-bonn.de
A research flyer about 3D craniofacial morphometry data collection, with a 3D rendered image of a human skull showing red markers on facial landmarks.

FaceBase

Enroll - email facebase@ucalgary.ca

REN Research Study on Rare Epilepsy Experiences

Research and Treatment Disclaimer

ReNU Syndrome United strongly encourages voluntary participation in patient registries and natural history studies, which can help researchers better understand the symptoms, progression, and impact of ReNU syndrome and support future research and therapeutic development. Participation in any registry, research study, clinical trial, or treatment decision should be based on informed consent and discussed with the participant’s qualified healthcare providers.

Some surveys and/or studies may be qualified for payment by the provider. RSU does not provide the compensation nor do we guarantee payments from any 3rd parties that you may register with.

Although RSU is hopeful about ongoing and future research, it does not endorse, recommend, guarantee, or attest to the safety, effectiveness, viability, regulatory approval, or availability of any investigational therapy or proposed treatment. Treatments may involve known and unknown risks, may not provide benefit, and may ultimately not be proven safe or effective. Information shared by RSU is for educational purposes only and is not medical advice or a substitute for individualized medical care.

Frequently Asked Questions

Exciting research is happening!

A collage showing a neural network, two zebrafish larvae, and four petri dish wells with handwritten numbers.

Exciting research is happening! Zebrafish (center) are used to study ReNU syndrome, for example examining brain changes (left) and behavior differences (right), providing insights into the disease.


Two scientists in a laboratory examining cells on a computer screen, with laboratory equipment in the background.

ReNU Syndrome United announces our 1st grant towards research! 

ReNU Syndrome United is thrilled to announce our financial support towards an important research initiative at KU Leuven aimed at better understanding the ReNU Syndrome disease mechanism and how this could affect brain development in children.

This work is led by Prof. Dr. Ir. Kathleen Freson, with co-leadership from Prof. Dr. Ernest Turro, and will support the postdoctoral research of Koen De Wispelaere. Together, the team is applying advanced stem cell research techniques to investigate how the genetic changes that cause ReNU syndrome affect the growth, connectivity, and function of brain cells.

The goal of these cell-based experiments is to shed light on how mutant RNU4-2 alters early brain development in children with ReNU Syndrome. Furthermore, the mutant neuronal cell lines the team will generate have the potential to facilitate preclinical testing of future treatments.

This project represents a meaningful step forward for the ReNU community, helping move from awareness toward deeper understanding and hope for the future.

To get meaningful data about the progression of RNU4-2 / ReNU syndrome, we need you to join Citizen Health!

Snapshot of registrants as of January 26, 2026:

What’s important to the RNU4-2 Community?

Take the Treatment Priority Poll

Initial analysis 26 January 2026, re-analysis 3 April 2026

Top 10 priorities in rank order, based on the weighted caregiver poll results:

  1. Absent / delayed speech & communication

  2. Epilepsy / seizures

  3. Brain abnormalities

  4. Mobility

  5. Low muscle tone (hypotonia) ⬆️ (moved up from #6)

  6. Feeding ⬇️ (shifted down one)

  7. Bone fragility

  8. Drooling

  9. Lower gastrointestinal issues (e.g., constipation)

  10. Short stature / poor growth 🆕 (replaces sleep disturbances)